Skip to content

Sirius in Gynaecological Laparoscopic Surgery

A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05048407
Enrollment
30
Registered
2021-09-17
Start date
2023-05-30
Completion date
2024-06-30
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer, Gynecologic Cancer, Ovarian Cancer

Brief summary

Precision Robotics' Sirius Robotic Flexible Endoscopic System is a new fully integrated compact 3D laparoscopic camera system with a disposable single-use flexible tip that can change its viewing direction. A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery. The study is a single-arm prospective study to evaluate the Performance and Safety of the SIRIUS Endoscope System.

Detailed description

Minimally invasive surgery (MIS) is well established in gynecological surgery. Compared to laparotomy, MIS is associated with reduced morbidity and quicker recovery. With advancement in laparoscopic technology and techniques, MIS in gynecology has progressed from multi-port to single incision laparoscopic surgery (SILS) and vaginal natural orifice transluminal endoscopic surgery (vNOTEs), thus further reducing morbidity and enhancing recovery. One of the challenges of MIS is the restriction of the range of surgical movement. To overcome these technical challenges, articulated instruments are increasingly being used. The SIRIUS Endoscope System is a new, fully integrated compact 3D laparoscopic camera system with a disposable single-use flexible tip that can change its viewing direction. The articulated tip has three degrees of freedom, enabling C and S-shaped bending, and providing a wider field of view compared to conventional laparoscopes. This wider field of view is of advantage for SILS and vNOTEs. Presently available commercial systems do not have the same field of view or degrees of freedom. A first in-human, proof of concept, and early development study of the SIRIUS Endoscope System was done at GHK in 2021 (HKU-GHK IRB 2021-01, ClinicalTrials.gov NCT05048407). The successful completion of 11 of 13 (85%) planned procedures in this sequentially reported, prospective case series, shows that the SIRIUS Endoscope System can be used with indications of safety, and efficacy for intermediate and major MIS laparoscopic procedures in gynecology. The findings have been submitted for consideration for publication. Based on the outcome of this study, further improvements to the SIRIUS Endoscope System have been made to enhance safety, reliability, and usability. This proposed prospective study is a confirmatory study to evaluate the performance and safety of the SIRIUS Endoscope System in preparation for regulatory approval.

Interventions

The laparoscopic procedures were done in the usual manner. The only difference was for the study participants, the Sirius System was used in place of the usual conventional laparoscope. All other procedures and instruments including the number of ports remained the same. For every procedure using the Sirius System, a conventional laparoscope was on immediate standby to replace the Sirius System should there be an unanticipated equipment failure so that the procedure could be completed without delay.

Sponsors

Gleneagles Hospital
CollaboratorOTHER
Precision Robotics (Hong Kong) Limited
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligible women, 18 or older, who are planned for laparoscopic gynaecological surgery and willing to provide informed consent prior to surgery

Exclusion criteria

1. Patient is pregnant, or planning on becoming pregnant 2. Obese patients (BMI \>35) 3. Patient with known contraindication(s) to Laparoscopic Gynecological Surgery 4. Patient with operations planned for longer than 4 hours 5. Subjects are considered ineligible for the study as judged by the investigator.

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the Performance and Safety of the SIRIUS Endoscope System articulated tip.Data will be collected during the operation and the analysis will be completed up to 1 month post-operationThe performance and safety of the endoscope system will be evaluated based on the outcome of the operation, in terms of patient blood lost and duration of the operation are comparable with the use of other conventional endoscope systems.

Secondary

MeasureTime frameDescription
To assess the amount of time of straight and bending positions of SIRIUS Endoscope System articulated tip. To evaluate the events of device deficiency and/or malfunctions of SIRIUS Endoscope System. To evaluate the Safety of SIRIUS Endoscope SystemData will be collected during the operation and it will be completed upon the completion of the operationTo assess the effectiveness of the bending function of the SIRIUS endoscope system by capturing the amount of time the SIRIUS endoscope is bent or straightened during the operation.

Countries

Hong Kong

Contacts

Primary ContactBenny Lo, PhD
b.lo@precisionrobotics.com+852 64785586
Backup ContactRuchita Mehta, MS
R.Mehta@precisionrobotics.com+852 70734437

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026